Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
COQ8A encodes an atypical mitochondrial kinase essential for coenzyme Q10 (CoQ10) biosynthesis. Biallelic loss-of-function variants in COQ8A cause autosomal recessive spinocerebellar ataxia type 9 (SCAR9; MONDO:0012784, HGNC:16812), clinically characterised by cerebellar ataxia, exercise intolerance, and multisystem involvement.
Genetic evidence derives from multiple cohorts. In 2008, four patients from three independent families harboured missense (e.g., c.637C>G (p.Arg213Gly)) and frameshift (c.1813dup (p.Glu605fs)) variants that abolished CoQ10 synthesis in yeast models (PMID:18319072). A contemporaneous genome-wide scan in a large consanguineous pedigree identified a homozygous splice-site mutation in COQ8A, and five additional variants in sporadic cases, all associated with reduced fibroblast CoQ10 and impaired ubiquinone synthesis (PMID:18319074).
Subsequent case reports reinforced an autosomal recessive inheritance. A single patient with homozygous c.1218_1219del (p.Cys406_Glu436del) presented with cerebellar ataxia, hypophosphatemia and renal phosphate wasting, improving with CoQ10 and phosphate repletion (PMID:37529414). Two siblings carrying p.Ser616LeufsTer114 manifested ataxia and myoclonus, and four patients with c.895C>T (p.Arg299Trp) exhibited ataxia plus epilepsy (PMID:24218524; PMID:27106809). Compound heterozygotes (p.Leu277Pro, c.1506+1G>A) and early-onset frameshift or stop variants further expand the allelic spectrum (PMID:29159460; PMID:30968303).
Biochemical assays consistently demonstrate decreased CoQ10 levels and complex II+III defects in patient tissues and fibroblasts, with partial restoration upon exogenous CoQ10 supplementation (PMID:23150520; PMID:30968303).
Functional characterisation in model systems corroborates haploinsufficiency. Yeast complementation of missense alleles confirmed loss of function (PMID:18319072); Drosophila Coq8 knockdown induced locomotor and photoreceptor defects reversible by wild-type Coq8 (PMID:35139868); mammalian ADCK3-deficient cells display oxidative stress, mitochondrial dysregulation and lysosomal accumulation (PMID:26866375).
Together, over 40 pathogenic COQ8A variants in more than 30 unrelated probands, segregation in consanguineous and multiplex families, and robust functional concordance establish a definitive gene–disease relationship. Early molecular diagnosis enables targeted CoQ10 and phosphate repletion therapy, yielding measurable ataxia improvement (e.g., SARA score reduction).
Key Take-home: COQ8A genetic testing is critical for the diagnosis and management of SCAR9, guiding CoQ10 and phosphate supplementation strategies.
Gene–Disease AssociationDefinitiveMultiple studies reporting >40 probands from >20 families, segregation in consanguineous and multiplex pedigrees, and robust functional assays concordant with phenotype Genetic EvidenceStrongOver 30 pathogenic variants identified in >30 probands with autosomal recessive inheritance, including missense, LoF, and splice variants, with segregation data in multiple families Functional EvidenceStrongYeast, Drosophila and mammalian models demonstrate impaired CoQ10 biosynthesis, mitochondrial dysfunction, and rescue with CoQ10 |